Vaximm AG has completed analysis of two clinical studies evaluating [...]

PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]

Deep Science Ventures and Medicines Discovery Catapult have launched a [...]

CNS Pharmaceuticals has reported the primary analysis of its clinical [...]

Telix Pharmaceuticals has reached agreement with the US Food and [...]

Medicines Discovery Catapult (MDC) and King’s College London (KCL) have [...]

Carthera has enrolled the first 100 participants in its Sonobird [...]